As of 2025-09-18, the Relative Valuation of Talaris Therapeutics Inc (TALS) is (23.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.72 USD, the upside of Talaris Therapeutics Inc based on Relative Valuation is -965.3%.
The range of the Relative Valuation is (24.28) - (23.58) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 13.9x | 13.9x |
| Forward P/E multiples | 12.6x - 13.5x | 13.0x |
| Fair Price | (24.28) - (23.58) | (23.54) |
| Upside | -992.6% - -966.9% | -965.3% |
| Date | P/E |